Genmab A/S Amortisation Expense
Genmab A/S (GMAB) reported Amortisation Expense of $16.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AmortisationExpense · last filed 2026-02-17
DKK
| Period end | Amortisation Expense 6 month | Amortisation Expense 12 month |
|---|---|---|
| 2024-12-31 | 78.00M DKK 6-K · filed 2025-02-12 | |
| 2024-06-30 | 26.00M DKK 6-K · filed 2024-08-08 | |
| 2023-12-31 | 55.00M DKK 6-K · filed 2025-02-12 | |
| 2023-06-30 | 27.00M DKK 6-K · filed 2024-08-08 | |
| 2022-12-31 | 108.00M DKK 6-K · filed 2025-02-12 |
USD
| Period end | Amortisation Expense 6 month | Amortisation Expense 12 month |
|---|---|---|
| 2025-12-31 | $16.00M 20-F · filed 2026-02-17 | |
| 2025-06-30 | $7.00M 6-K · filed 2025-08-07 | |
| 2024-12-31 | $11.00M 20-F · filed 2026-02-17 | |
| 2024-06-30 | $4.00M 6-K · filed 2025-08-07 | |
| 2023-12-31 | $8.00M 20-F · filed 2026-02-17 |